共 50 条
Hematopoietic-Stem-Cell-Based Gene Therapy for HIV Disease
被引:100
|作者:
Kiem, Hans-Peter
[2
,4
,5
]
Jerome, Keith R.
[3
,6
]
Deeks, Steven G.
[7
]
McCune, Joseph M.
[1
]
机构:
[1] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA
[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA
[3] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA
[4] Univ Washington, Dept Med, Seattle, WA 98109 USA
[5] Univ Washington, Dept Pathol, Seattle, WA 98109 USA
[6] Univ Washington, Dept Lab Med, Seattle, WA 98109 USA
[7] Univ Calif San Francisco, HIV AIDS Program, San Francisco, CA 94110 USA
关键词:
BLOOD PROGENITOR CELLS;
MARROW REPOPULATING CELLS;
IN-VIVO;
T-CELLS;
MULTILINEAGE HEMATOPOIESIS;
EFFICIENT TRANSDUCTION;
LENTIVIRAL VECTOR;
MURINE MARROW;
SELF-RENEWAL;
IMMUNODEFICIENCY;
D O I:
10.1016/j.stem.2011.12.015
中图分类号:
Q813 [细胞工程];
学科分类号:
摘要:
Although combination antiretroviral therapy can dramatically reduce the circulating viral load in those infected with HIV, replication-competent virus persists. To eliminate the need for indefinite treatment, there is growing interest in creating a functional HIV-resistant immune system through the use of gene-modified hematopoietic stem cells (HSCs). Proof of concept for this approach has been provided in the instance of an HIV-infected adult transplanted with allogeneic stem cells from a donor lacking the HIV coreceptor, CCR5. Here, we review this and other strategies for HSC-based gene therapy for HIV disease. © 2012 Elsevier Inc.
引用
收藏
页码:137 / 147
页数:11
相关论文